On                       our CEO Victoria Clare delivered a speech at the All-Party Parliamentary Group on Women’s Health urging the policymakers and MPs present to be ambitious and to set meaningful targets that will improve outcomes for ovarian cancer in the UK.

Most recent statistics indicate that approximately 4 out of 10 women diagnosed with ovarian cancer in England in 2022 and Wales in 2023 had an emergency admission within 28 days prior to their diagnosis. Only 74.2% of those diagnosed with stage 2, 3 or 4 (or unstaged) ovarian cancer received any treatment in England in 2022, 80.3% in Wales in 2023. Though the State of the nation report did not include statistics in Scotland or Northern Ireland, we know that the same recommendations would benefit patients throughout the UK.

"I have heard countless stories from women who have struggled to receive information, diagnosis and support for their health concerns.” Says Gill Furniss, Chair of the APPG. “The pattern is clear: women’s pain is normalised, their symptoms are dismissed too easily, and they are not listened to” 

Ovacome wants to see policy makers and politicians commit to making changes and putting resources in place to improve things for everyone affected by ovarian cancer. We will continue to work to make patient voices heard and improve outcomes for ovarian cancer.